18 related articles for article (PubMed ID: 7834464)
1. Relationship between diversion colitis and quality of life in rectal cancer.
Son DN; Choi DJ; Woo SU; Kim J; Keom BR; Kim CH; Baek SJ; Kim SH
World J Gastroenterol; 2013 Jan; 19(4):542-9. PubMed ID: 23382634
[TBL] [Abstract][Full Text] [Related]
2. Patterns of recurrence following pelvic exenteration and external radiotherapy for locally advanced primary rectal adenocarcinoma.
Luna-Perez P; Delgado S; Labastida S; Ortiz N; Rodriguez D; Herrera L
Ann Surg Oncol; 1996 Nov; 3(6):526-33. PubMed ID: 8915483
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer.
Grann A; Minsky BD; Cohen AM; Saltz L; Guillem JG; Paty PB; Kelsen DP; Kemeny N; Ilson D; Bass-Loeb J
Dis Colon Rectum; 1997 May; 40(5):515-22. PubMed ID: 9152176
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
J Clin Oncol; 1992 Jan; 10(1):79-84. PubMed ID: 1727928
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Saltz L; Frankel J
Cancer; 1993 Jun; 71(11):3486-92. PubMed ID: 8490898
[TBL] [Abstract][Full Text] [Related]
6. Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Schwartz G; Saltz L; Dougherty J; Frankel J; Wiseberg J
Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):821-7. PubMed ID: 8478232
[TBL] [Abstract][Full Text] [Related]
7. Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.
Nabhan C; Ragam A; Samuels B; Milton DT; Prasad L; Hooberman A; Hartsell W; Anthony A; Weisman R; Bitran JD
Clin Colorectal Cancer; 2007 Mar; 6(6):436-41. PubMed ID: 17531107
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer.
Minsky BD; Cohen AM; Enker WE; Kelsen DP; Kemeny N; Frankel J
Cancer Invest; 1995; 13(1):1-7. PubMed ID: 7834464
[TBL] [Abstract][Full Text] [Related]
9. Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
Rougier P; Nordlinger B
Ann Oncol; 1993; 4 Suppl 2():21-8. PubMed ID: 8353101
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
